Treating eye cancer patients in their 80s, 90s, and even older, present a unique set of physical and ethical challenges. A case report written by Dr. Carina Sanvicente and Dr. Paul Finger, and published in the November issue of EyeNet, demonstrates how successful treatment can improve quality of life even for patients of advanced age. [..] Read More…
Patients diagnosed with choroidal melanoma run the risk of having the cancer spread to other parts of their body. In fact, medical evidence suggests half of all choroidal melanoma patients will develop metastatic disease. However, Dr. Paul Finger’s says, “It’s not that simple.” Studies have pinpointed a number of factors shown to affect the spread [..] Read More…
It makes a difference where you are treated. Knowing the right questions to ask will help you decide. We have developed a list of 7 key questions that will help you evaluate prospective physicians. Getting answers to these questions will help you be sure the doctor you chose has the experience necessary to provide the [..] Read More…
A doctor who recently completed fellowship training supported by The Eye Cancer Foundation (ECF) is providing eye cancer treatment in an area of India currently lacking any trained specialists in ocular oncology. Dr. Bikramjit Pal worked under Dr. Tero Kivelä at the Helsinki University Eye Hospital during his six-month fellowship from October 2015 through March [..] Read More…
Every year, retinoblastoma afflicts some 10,000 children around the world. This eye cancer has a 98% cure rate with proper diagnosis and treatment, but many children in less developed countries lose their vision and even their lives because of lack of access to proper care. Through the recently launched 2020 Campaign, The Eye Cancer Foundation [..] Read More…
Researchers have identified the critical role of a cancer-promoting gene in the growth and survival of retinoblastoma cells. This discovery could lead to new treatment options. Retinoblastoma is the most common intraocular childhood cancer. It affects approximately 300 children in the United States each year and more than 8,000 worldwide. When detected early, the cure rate [..] Read More…
Despite the many vision-saving eye cancer treatments available, sometimes it becomes necessary to remove an eye. For patients facing enucleation surgery, the prospect of losing an eye is scary. Fortunately, most patients can see with their remaining eye and will most likely be able to do all the things they used to do before, including [..] Read More…
Ata Rajeh, MD recently completed fellowship training in ocular oncology under Yacoub Yousef, MD of Jordan. The training was supported by The Eye Cancer Foundation (ECF). ECF fellowships are available to candidates from unserved or underserved countries. Once the doctors complete their six months of training, they agree to return to their home country to start [..] Read More…
The Eye Cancer Foundation is proud to be joining forces with the International Council of Ophthalmology supporting and promoting eye cancer fellowship education for doctors from unserved and underserved countries. Since launching its ICO fellowship program in 2001, more than 920 Fellows have completed a three month subspecialty training and 28 ICO Fellows have completed [..] Read More…
A study recently published in the Journal of Clinical Oncology showed revamping multi-drug chemotherapy for retinoblastoma to include tropotecan maintained high cure rates while preserving vision and reducing the risk of treatment related leukemia. Retinoblastoma ranks as the most common intraocular childhood cancer. It affects approximately 300 children in the United States each year and [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
